Search

everythinglearnresearchcommunity

for

Search:↓

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

Fascial Manipulation treatment helped a woman with vulvodynia and other health issues.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Women with PCOS have more emotional and body image issues than healthy women.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Post-finasteride syndrome's existence is uncertain; more research needed.

About 40% of women without hair loss and 60% with hair loss experience a lot of hair shedding, especially those under 50 with long hair.

Trichotillometry is a reliable method to measure hair strength and assess hair loss treatments.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Multimedia education greatly improves women's knowledge and management of PCOS.

Combining Traditional Chinese Medicine and Western medicine can improve symptoms, hormone levels, and pregnancy outcomes in Polycystic Ovary Syndrome patients, but more research is needed.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.